Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rate-dependence of antiarrhythmic drug action.
Singh BN, Wadhani N, Sarma JS. Singh BN, et al. Among authors: wadhani n. J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):203-6. doi: 10.1177/107424840200700401. J Cardiovasc Pharmacol Ther. 2002. PMID: 12490964 Review. No abstract available.
Lipid-lowering therapy in patients with peripheral arterial disease.
Ebrahimi R, Saleh JR, Toggart EJ, Hayatdavoudi B, Wolf CJ, Wadhani NN, Shah AP. Ebrahimi R, et al. Among authors: wadhani nn. J Cardiovasc Pharmacol Ther. 2004 Dec;9(4):271-7. doi: 10.1177/107424840400900407. J Cardiovasc Pharmacol Ther. 2004. PMID: 15678246 Review.
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.
Moliterno DJ; TENACITY Steering Committee and Investigators. Moliterno DJ, et al. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9. doi: 10.1002/ccd.22876. Epub 2011 Jan 11. Catheter Cardiovasc Interv. 2011. PMID: 21598351 Clinical Trial.